Alexandria Real Estate Equities

ARE · NYSE

$42.65+$0.14 (+0.33%)TodayMarket closed · Oct 21, 4:43 AM ET

Prev close $42.51

About ARE

Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 514 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.

Employees: 514
Headquarters: Pasadena, California
Listed: May 28, 1997
Sector: Real Estate
Industry: Health Care REITs
Website: are.com

Leadership

Alexandria Real Estate Equities executives
Name	Title	Since	Age
Joel Marcus	—	1994	77
John Cole	—	—	39
Hunter Kass	—	—	42
Peter Moglia	—	—	58
Marc Binda	—	—	49
Lawrence Diamond	—	—	66
Joseph Hakman	—	—	54
Madeleine Alsbrook	—	—	42
Gary Dean	—	—	53
Kristina Fukuzaki-Carlson	—	—	50
Orraparn Lee	—	—	42
Andres Gavinet	—	—	56
Jackie Clem	—	—	56
Steven Hash	—	—	60
Claire Aldridge	—	—	55
Amb. James Cain	—	—	67
Maria Freire	—	—	71
Richard Klein	—	—	69
Sheila Mcgrath	—	—	60
Michael Woronoff	—	—	64

Revenue by product and region

Fiscal year ended Dec 31, 2020: $1.89B total revenue

By product

Income from rentals$1.88B99.6%
Income from rentals$1.88B99.6%
Income from rentals$1.88B99.6%
Revenues subject to other accounting guidance$28.70M1.5%
Other income$7.43M0.4%
Other income$7.43M0.4%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Alexandria Real Estate Equities suppliers and customers
Company	Relationship	Country	Correlation
Moderna MRNA	Customer	—	0.94
Pfizer PFE	Customer	—	0.91
Facebook A FB	Customer	—	0.90
Roche Holding ROG.SW	Customer	—	0.88
Eli Lilly LLY	Customer	—	0.86
Illumina, Inc. ILMN	Customer	—	0.75
Bristol-Myers Squibb Company BMY	Customer	—	0.73
Novartis NOVN.SW	Customer	—	0.61
Sanofi SAN.PA	Customer	—	0.54
Takeda Pharmaceutical	Customer	—	0.00

Similar companies

Companies in the same industry as Alexandria Real Estate Equities

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.